Michigan Medicine, Division of Gastroenterology and Hepatology
Welcome,         Profile    Billing    Logout  
 10 Trials 
17 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Oral, Elif A
NCT04026178: Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy

Active, not recruiting
4
10
US
Metreleptin
Aegerion Pharmaceuticals, Inc.
Generalized Lipodystrophy
10/24
04/25
NCT05351164: Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)

Active, not recruiting
2
4
US
Metreleptin
University of Michigan, Amryt Pharma
Lipomatosis, Multiple Symmetrical
04/24
04/25
LEAP, NCT05088460: A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD)

Terminated
2
20
Europe, US, RoW
REGN4461, mibavademab, Matching Placebo
Regeneron Pharmaceuticals
Familial Partial Lipodystrophy, Metabolic Abnormalities
10/23
04/24
NCT02404896: Expanded Access Metreleptin Study

Available
N/A
US
Metreleptin, MyaLept
University of Michigan
Familial Partial Lipodystrophy
 
 
STEP-1, NCT04101669: EndoBarrier System Pivotal Trial(Rev E v2)

Recruiting
N/A
240
US
EndoBarrier Liner, EndoBarrier Sleeve, Duodenal-jejunal Bypass Liner (DJBL), Sham
GI Dynamics, Biostatistical Consulting, Inc.
Diabetes type2, Obesity
04/24
04/25
REVITA-T2Di, NCT04419779: Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes

Recruiting
N/A
320
Europe, US
Duodenal Mucosal Resurfacing (DMR), Duodenal Mucosal Resurfacing (Sham)
Fractyl Health Inc.
Type 2 Diabetes
06/24
01/26
NCT03087253: The LD Lync Study - Natural History Study of Lipodystrophy Syndromes

Recruiting
N/A
500
US, RoW
University of Michigan
Lipodystrophy (Genetic or Acquired, Non HIV)
03/31
03/31
MEASuRE, NCT02325674: Metreleptin Effectiveness And Safety Registry

Recruiting
N/A
100
Europe, US
Aegerion Pharmaceuticals, Inc.
Generalised Lipodystrophy, Partial Lipodystrophy
10/31
10/31
RADIANT, NCT05544266: Rare and Atypical Diabetes Network

Recruiting
N/A
2000
US
University of South Florida, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Mellitus, Diabetes Mellitus Progression, Glucose Intolerance, Glucose Metabolism Disorders, Metabolic Disease, Endocrine; Complications, Endocrine System Diseases
09/30
09/30
Kwon, Richard s
STEP-1, NCT04101669: EndoBarrier System Pivotal Trial(Rev E v2)

Recruiting
N/A
240
US
EndoBarrier Liner, EndoBarrier Sleeve, Duodenal-jejunal Bypass Liner (DJBL), Sham
GI Dynamics, Biostatistical Consulting, Inc.
Diabetes type2, Obesity
04/24
04/25
NCT04764396: Assessing Effects of Heparin Priming and Pass Number on Tissue Quality of Fine Needle Biopsies

Terminated
N/A
2
US
Heparin will be used for needle priming (BD PosiFlush™ Pre-Filled Heparin Lock Flush Syringe), Saline
University of Michigan
Pancreas, Mass Lesion
04/21
07/21
EA2185, NCT04239573: Comparing Two Methods to Follow Patients With Pancreatic Cysts

Recruiting
N/A
4606
Canada, US, RoW
Computed Tomography, CAT, CAT scan, Computerized Axial Tomography, computerized tomography, CT, CT scan, tomography, Endoscopic Ultrasound, endosonography, EUS, Magnetic Resonance Imaging, Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, nuclear magnetic resonance imaging, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Pancreatic Carcinoma
07/33
07/33
Law, Ryan
NCT06174805: AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE

Not yet recruiting
N/A
67
Europe, Canada, US, RoW
AXIOS(TM) Stent and Electrocautery Enhanced Delivery System
Boston Scientific Corporation
Gastric Outlet Obstruction
08/26
08/26
Schulman, Allison R
STEP-1, NCT04101669: EndoBarrier System Pivotal Trial(Rev E v2)

Recruiting
N/A
240
US
EndoBarrier Liner, EndoBarrier Sleeve, Duodenal-jejunal Bypass Liner (DJBL), Sham
GI Dynamics, Biostatistical Consulting, Inc.
Diabetes type2, Obesity
04/24
04/25
Krafton, Andrew T
STEP-1, NCT04101669: EndoBarrier System Pivotal Trial(Rev E v2)

Recruiting
N/A
240
US
EndoBarrier Liner, EndoBarrier Sleeve, Duodenal-jejunal Bypass Liner (DJBL), Sham
GI Dynamics, Biostatistical Consulting, Inc.
Diabetes type2, Obesity
04/24
04/25
Volk, Sarah
STEP-1, NCT04101669: EndoBarrier System Pivotal Trial(Rev E v2)

Recruiting
N/A
240
US
EndoBarrier Liner, EndoBarrier Sleeve, Duodenal-jejunal Bypass Liner (DJBL), Sham
GI Dynamics, Biostatistical Consulting, Inc.
Diabetes type2, Obesity
04/24
04/25
PRECEDE, NCT04970056: Pancreatic Cancer Early Detection Consortium

Recruiting
N/A
8000
Europe, Canada, US, RoW
Arbor Research Collaborative for Health
Pancreas Cancer, Pancreas Cyst, Pancreatic Ductal Adenocarcinoma, Genetic Predisposition
12/30
12/30

Download Options